Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Australian Clinical Labs Ltd has reported a change in the holdings of its substantial shareholder, First Sentier Investors, with an updated voting power of 8.92%. The notice highlights a significant adjustment in the number of shares and voting rights, reflecting the involvement of First Sentier Investors Holdings Pty Limited and its parent, Mitsubishi UFJ Financial Group. The changes in shareholdings are detailed in relation to the Corporations Act 2001 requirements, indicating a strategic shift in the company’s investor base.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.